Bio
Jim is a member of the firm’s Employee Benefits & Executive Compensation practice group, where he advises clients from a wide range of industries on complex executive compensation and employee benefits matters.
Jim plays a key role in supporting the firm’s Mergers & Acquisitions practice group, counseling private and public company buyers and sellers on the full spectrum of compensation and benefits issues arising in corporate transactions. He frequently advises both companies and executives on equity compensation arrangements, deferred compensation under Code Section 409A and the golden parachute provisions under Code Section 280G.
His practice also includes advising private investment funds on ERISA matters related to the plan asset regulations and the formation and operation of venture capital operating companies (VCOCs).
Outside the transactional space, Jim assists clients with their employee benefit programs, executive compensation arrangements, ESOPs, and health and welfare plans. He counsels clients on plan corrections for both qualified and nonqualified plans, regulatory compliance, plan design, and matters involving employee benefit plan issues before the Internal Revenue Service and the U.S. Department of Labor.
Prior to joining the firm, Jim practiced as in-house ERISA counsel for a national employee benefits consulting firm in its Indianapolis office. Before attending law school, Jim worked as an athletic trainer in the National Football League. He received his undergraduate degree in Sports Medicine from Purdue University and his J.D. from the Valparaiso University School of Law. While in law school, Jim worked as a summer associate for the National Football League in New York City, focusing on labor and employment, compensation, and benefits matters.
Jim is admitted to practice in North Carolina and Indiana.
- Listed among North Carolina Super Lawyers: Employee Benefits – Rising Star (2026)
- Represented publicly listed biopharmaceutical company with a variety of executive compensation and employee benefits matters, including Code Section 280G in the spin out of its subsidiary via a $675 million de-SPAC transaction and subsequent listing as a publicly traded company.
- Represented a leading provider of regulated material management services in a strategic growth investment from a leading healthcare-focused private equity firm.
- Represented a leading designer and manufacturer of building safety systems with a variety of cross boarder employee benefits and executive compensation matters during its sale to a private equity backed acquirer.
- Represented Thermo Fisher in a $912.5 million acquisition of a private equity-backed leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies.
- Represented international waste management company in $380 million acquisition of a private equity-backed multi-State waste management company.
- Advised international waste management company on various employee benefits and executive compensation issues including defined benefit multiemployer withdrawal liabilities in connection with $110 million acquisition of a waste collection, recycling, and disposal business.
- Represented flyExclusive, a leading provider of premium jet charter experiences, with various employee benefits and executive compensation matters in its de-SPAC transaction valued at $600 million and subsequent listing as a publicly traded company on the NYSE American stock exchange.
- February 2, 2026 Deadline For Notices to Employees Who Purchased Stock in 2025 Through Stock Options or Employee Stock Purchase Plans
- Key Employee Benefits Changes Under the One Beautiful Bill Act
- The DOL Announces Updates to its Voluntary Fiduciary Compliance Program (VFCP)
- New Rules for ACA Reporting Now in Effect
- January 31, 2025 Deadline For Notices to Employees Who Purchased Stock in 2024 Through Stock Options or Employee Stock Purchase Plans
- January 31, 2023 Deadline For Notices to Employees Who Purchased Stock in 2022 Through Stock Options or Employee Stock Purchase Plans
- Dollar Limitations for Employee Benefit Plans
- Client Alert: Yet Another Required Notice: COBRA Subsidy Expiration Date and Notice Requirement Approaching